New Zealand research to fly on International Space Station
Dr Sarah Kessans. A research facility prototype developed in Christchurch will soon orbit Earth aboard the International Space Station (ISS) under a partnership between the Ministry of Business, Innovation and Employment (MBIE) and US space company Axiom Space. The facility for studying protein crystal growth in space, developed by Senior Lecturer at the University of Canterbury’s School of Product Design, Dr Sarah Kessans, in collaboration with teams from Arizona State University and Christchurch companies Asteria Engineering Consultancy and Intranel, was one of two projects selected for initial feasibility studies in 2022. “We signed a Memorandum of Understanding with Axiom last year and agreed to two feasibility studies, one of which led to Dr Kessans’ project,” MBIE Director of Innovative Partnerships Joe McKay said. “This facility could lead to major advances in medical, biotechnological, food science, and agricultural innovation and we are excited to support the next step.” Sarah’s research facility is scheduled to fly on Axiom Mission 3 (Ax-3) later this year, which will be the third private astronaut mission to the ISS. “Being able to conduct this research on the ISS is such a huge opportunity and really is critical to what we’re trying to achieve in terms of scientific innovation and future commercial outcomes,” Sarah said. “When protein crystals are grown in microgravity, they can develop into larger and higher quality crystals than what we can grow on Earth. These crystals can then be used to create high-resolution pictures of the protein’s structure. If we have a detailed picture of what virus proteins look like, for example, we can develop things like antiviral drugs and vaccines.” Current facilities for protein crystal growth on the Space Station require significant time and resources for astronauts to mix samples, set up experiments, observe growth and adjust settings as needed. By developing […]